HPV Ends Here: Increasing Uptake of the HPV Vaccine
Recruiting
N/A
Interventional Study
HPV Vaccine
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 10 – 12
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 2,232 (estimated)
- Sponsor
- University of California, Davis · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
• Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine
Exclusion Criteria:
• Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.
Contacts